BioCentury
ARTICLE | Company News

Bioventix Ltd., Xenova deal

January 12, 2004 8:00 AM UTC

In line with its declared strategy, XEN sold to Bioventix certain assets obtained through its acquisition of KS Biomedix for £800,000 ($1.4 million) (see BioCentury, Aug. 18, 2003). The sale includes ...